These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Evaluation of the correlation between insulin like factor 3, polycystic ovary syndrome, and ovarian maldescent. Seyam E, Hefzy E. Gynecol Endocrinol; 2018 Jun; 34(6):481-488. PubMed ID: 29254383 [Abstract] [Full Text] [Related]
10. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome. Wu J, Zhu Y, Jiang Y, Cao Y. Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522 [Abstract] [Full Text] [Related]
11. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome. Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS. Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325 [Abstract] [Full Text] [Related]
13. Follicle luteinization in hyperandrogenic follicles of polycystic ovary syndrome patients undergoing gonadotropin therapy for in vitro fertilization. Foong SC, Abbott DH, Zschunke MA, Lesnick TG, Phy JL, Dumesic DA. J Clin Endocrinol Metab; 2006 Jun; 91(6):2327-33. PubMed ID: 16551732 [Abstract] [Full Text] [Related]
14. Angiotensin II type 2 receptor stimulation improves fatty acid ovarian uptake and hyperandrogenemia in an obese rat model of polycystic ovary syndrome. Leblanc S, Battista MC, Noll C, Hallberg A, Gallo-Payet N, Carpentier AC, Vine DF, Baillargeon JP. Endocrinology; 2014 Sep; 155(9):3684-93. PubMed ID: 24971613 [Abstract] [Full Text] [Related]
18. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. Yang Z, Zhou W, Zhou C, Zhou Y, Liu X, Ding G, Hu Y, Pan J, Sheng J, Jin L, Huang H. J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681 [Abstract] [Full Text] [Related]